Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia

Diabetic Medicine : a Journal of the British Diabetic Association
J D Goldhaber-FiebertK Eggleston

Abstract

The prevalence of Type 2 diabetes mellitus (DM) has grown rapidly, but little is known about the drivers of inpatient spending in low- and middle-income countries. This study aims to compare the clinical presentation and expenditure on hospital admission for inpatients with a primary diagnosis of Type 2 DM in India, China, Thailand and Malaysia. We analysed data on adult, Type 2 DM patients admitted between 2005 and 2008 to five tertiary hospitals in the four countries, reporting expenditures relative to income per capita in 2007. Hospital admission spending for diabetic inpatients with no complications ranged from 11 to 75% of per-capita income. Spending for patients with complications ranged from 6% to over 300% more than spending for patients without complications treated at the same hospital. Glycated haemoglobin was significantly higher for the uninsured patients, compared with insured patients, in India (8.6 vs. 8.1%), Hangzhou, China (9.0 vs. 8.1%), and Shandong, China (10.9 vs. 9.9%). When the hospital admission expenditures of the insured and uninsured patients were statistically different in India and China, the uninsured always spent less than the insured patients. With the rising prevalence of DM, households and hea...Continue Reading

References

Jul 1, 1993·Diabetes Research and Clinical Practice·C S CockramS P Donnan
Mar 8, 2000·Diabetes Research and Clinical Practice·R ShobhanaA Ramachandran
Oct 13, 2001·Diabetologia·A RamachandranUNKNOWN Diabetes Epidemiology Study Group in India (DESI)
Mar 5, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·A RamachandranH King
Aug 8, 2002·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·W P JiaY M Wu
Mar 25, 2005·Pediatric Diabetes·Thomas ReinehrUNKNOWN DPV-Wiss Study Group
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·Y DongQ Qiao
Nov 18, 2005·Lancet·Andrew J M BoultonJan Apelqvist
Dec 6, 2005·International Journal of Epidemiology·Andrew M Prentice
Jul 17, 2007·Health Affairs·Ke XuTimothy Evans
Sep 21, 2007·Health Economics·Karen EgglestonAdam Wagstaff
Mar 11, 2008·Social Science & Medicine·Dele Olawale Abegunde, Anderson E Stanciole
Nov 26, 2008·Bulletin of the World Health Organization·Adam Leive, Ke Xu
Nov 17, 2009·Diabetes Research and Clinical Practice·R K SimmonsS J Griffin

❮ Previous
Next ❯

Citations

Dec 14, 2011·International Journal of Clinical Practice·X Z He
Aug 21, 2013·Health Research Policy and Systems·Hyacinthe Tchewonpi KankeuDavid B Evans
Mar 19, 2013·Globalization and Health·Chaicharn Deerochanawong, Alessandra Ferrario
Jan 15, 2014·Diabetes Research and Clinical Practice·Juliana C N ChanJonathan Shaw
Aug 15, 2014·Indian Journal of Nephrology·K SatyavaniV Viswanathan
Feb 20, 2016·Current Diabetes Reports·Sirimon Reutrakul, Chaicharn Deerochanawong
Dec 21, 2014·European Journal of Epidemiology·Loes JaspersOscar H Franco
Jan 13, 2012·Diabetes Care·Crystal M Smith-SpanglerJeremy D Goldhaber-Fiebert
Jul 30, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·Q LongS Tang
Dec 9, 2017·Nature Reviews. Endocrinology·Yan ZhengFrank B Hu
Apr 4, 2018·Applied Health Economics and Health Policy·Indrani Gupta, Arjun Roy
Aug 14, 2020·International Journal of Environmental Research and Public Health·Kurubaran GanasegeranIrene Looi
Jan 10, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tarique HussainYulong Yin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.